Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters

Database
Language
Document Type
Year range
1.
BMC Infect Dis ; 21(1): 353, 2021 Apr 15.
Article in English | MEDLINE | ID: covidwho-1190057

ABSTRACT

BACKGROUND: The primary objective of the study is to describe the cellular characteristics of bronchoalveolar lavage fluid (BALF) of COVID-19 patients requiring invasive mechanical ventilation; the secondary outcome is to describe BALF findings between survivors vs non-survivors. MATERIALS AND METHODS: Patients positive for SARS-CoV-2 RT PCR, admitted to ICU between March and April 2020 were enrolled. At ICU admission, BALF were analyzed by flow cytometry. Univariate, multivariate and Spearman correlation analyses were performed. RESULTS: Sixty-four patients were enrolled, median age of 64 years (IQR 58-69). The majority cells in the BALF were neutrophils (70%, IQR 37.5-90.5) and macrophages (27%, IQR 7-49) while a minority were lymphocytes, 1%, TCD3+ 92% (IQR 82-95). The ICU mortality was 32.8%. Non-survivors had a significantly older age (p = 0.033) and peripheral lymphocytes (p = 0.012) were lower compared to the survivors. At multivariate analysis the percentage of macrophages in the BALF correlated with poor outcome (OR 1.336, CI95% 1.014-1.759, p = 0.039). CONCLUSIONS: In critically ill patients, BALF cellularity is mainly composed of neutrophils and macrophages. The macrophages percentage in the BALF at ICU admittance correlated with higher ICU mortality. The lack of lymphocytes in BALF could partly explain a reduced anti-viral response.


Subject(s)
Bronchoalveolar Lavage Fluid/cytology , Bronchoalveolar Lavage Fluid/immunology , COVID-19/epidemiology , COVID-19/immunology , Leukocyte Count , Pneumonia, Viral/epidemiology , Pneumonia, Viral/immunology , Respiration, Artificial , Adult , Aged , Bronchoalveolar Lavage Fluid/virology , COVID-19/mortality , COVID-19/virology , Critical Illness/epidemiology , Female , Humans , Intensive Care Units , Italy/epidemiology , Lymphocytes/cytology , Macrophages/cytology , Male , Middle Aged , Neutrophils/cytology , Pneumonia, Viral/mortality , Pneumonia, Viral/virology , SARS-CoV-2/immunology , SARS-CoV-2/pathogenicity , Survivors/statistics & numerical data , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL